DAPT including aspirin and P2Y12 inhibitors is the treatment of choice for the secondary prevention of atherothrombotic events in patients with coronary artery disease, especially those undergoing PCI with stent placement. The gene discussed is P2RY12; the disease is coronary artery disorder.